Abstract
https://pubmed.ncbi.nlm.nih.gov/33485973/
Ethnopharmacological relevance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19), a highly pathogenic virus that has spread rapidly across the entire world. There is a critical need to develop safe and effective drugs, especially broad-spectrum antiviral and organ protection agents in order to treat and prevent this dangerous disease. It is possible that Chinese herbal medicine may play an essential role in the treatment of patients with SARS-CoV-2 infection.
Aim of the review: We aim to review the use of Chinese herbal medicine in the treatment of COVID-19 both in vitro and in clinical practice. Our goal was to provide a better understanding of the potential therapeutic effects of Chinese herbal medicine and to establish a “Chinese protocol” for the treatment of COVID-19.
Materials and methods: We systematically reviewed published research relating to traditional Chinese herbal medicines and the treatment of SARS-CoV-2 from inception to the 6th January 2021 by screening a range of digital databases (Web of Science, bioRxiv, medRxiv, China National Knowledge Infrastructure, X-MOL, Wanfang Data, Google Scholar, PubMed, Elsevier, and other resources) and public platforms relating to the management of clinical trials. We included the active ingredients of Chinese herbal medicines, monomer preparations, crude extracts, and formulas for the treatment of COVID-19. 6, 2021.
Results: In mainland China, a range of Chinese herbal medicines have been recognized as very promising anti-SARS-CoV-2 agents, including active ingredients (quercetagetin, osajin, tetrandrine, proscillaridin A, and dihydromyricetin), monomer preparations (xiyanping injection, matrine-sodium chloride injection, diammonium glycyrrhizinate enteric-coated capsules, and sodium aescinate injection), crude extracts (Scutellariae Radix extract and garlic essential oil), and formulas (Qingfei Paidu decoction, Lianhuaqingwen capsules, and Pudilan Xiaoyan oral liquid). All these agents have potential activity against SARS-CoV-2 and have attracted significant attention due to their activities both in vitro and in clinical practice.
Conclusions: As a key component of the COVID-19 treatment regimen, Chinese herbal medicines have played an irreplaceable role in the treatment of SARS-CoV-2 infection. The “Chinese protocol” has already demonstrated clear clinical importance. The use of Chinese herbal medicines that are capable of inhibiting SARS-Cov-2 infection may help to address this immediate unmet clinical need and may be attractive to other countries that are also seeking new options for effective COVID-19 treatment. Our analyses suggest that countries outside of China should also consider protocols involving Chinese herbal medicines combat this fast-spreading viral infection.
Keywords: Chinese herbal medicine; SARS-Cov-2; active ingredients; broad-spectrum antiviral; organ protection.
Copyright © 2021 Elsevier B.V. All rights reserved.
Figures
Similar articles
- Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Su HX, Yao S, Zhao WF, Li MJ, Liu J, Shang WJ, Xie H, Ke CQ, Hu HC, Gao MN, Yu KQ, Liu H, Shen JS, Tang W, Zhang LK, Xiao GF, Ni L, Wang DW, Zuo JP, Jiang HL, Bai F, Wu Y, Ye Y, Xu YC. Acta Pharmacol Sin. 2020 Sep;41(9):1167-1177. doi: 10.1038/s41401-020-0483-6. Epub 2020 Jul 31. PMID: 32737471 Free PMC article.
- Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. Ren X, Shao XX, Li XX, Jia XH, Song T, Zhou WY, Wang P, Li Y, Wang XL, Cui QH, Qiu PJ, Zhao YG, Li XB, Zhang FC, Li ZY, Zhong Y, Wang ZG, Fu XJ. J Ethnopharmacol. 2020 Aug 10;258:112932. doi: 10.1016/j.jep.2020.112932. Epub 2020 May 4. PMID: 32376368 Free PMC article.
- A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19). Huang F, Li Y, Leung EL, Liu X, Liu K, Wang Q, Lan Y, Li X, Yu H, Cui L, Luo H, Luo L. Pharmacol Res. 2020 Aug;158:104929. doi: 10.1016/j.phrs.2020.104929. Epub 2020 May 20. PMID: 32442720 Free PMC article. Review.
- [Rationality of Asari Radix et Rhizoma in Qingfei Paidu Decoction based on literature analysis]. Qin ZN, Wang MX, Shi NN, Wang YP, Zhai HQ. Zhongguo Zhong Yao Za Zhi. 2020 Apr;45(7):1515-1520. doi: 10.19540/j.cnki.cjcmm.20200305.501. PMID: 32489028 Chinese.
- [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus]. Zhang YS, Cong WH, Zhang JJ, Guo FF, Li HM. Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501. PMID: 32281335 Review. Chinese.
Posted on January 30, 2021
0